Effect of Transfer Energy Capacitive and Resistive Therapy on Pain and Range of Motion After Flexor Tendon Repair

Effect of Transfer Energy Capacitive and Resistive Therapy on Pain and Range of Motion After Flexor Tendon Repair

The purpose of this study is to evaluate the impact of Transfer Energy Capacitive and Resistive therapy (TECAR) on pain and range of motion (ROM) after hand flexor tendon repair.

Lacking satisfactory healing of intrasynovial tendons, such as the flexor tendons of the hand, is particularly challenging due to the formation of fibrous adhesions between the tendon, sheath and surrounding tissues which can further limit mobility.

Transfer Energy Capacitive and Resistive therapy (TECAR) enhances the body's natural ability to repair tissues and reduce pain by improving blood flow and promoting additional benefits, such as cell proliferation. This process, primarily linked to the flow of current, supports cell growth and plays a significant role in the healing process.

There is a lack in quantitative knowledge and information in the published studies about the benefits of TEcar therapy on the improvement of hand function after long flexor tendon repair . So, this study is designed to outline the therapeutic impact of TEcar therapy on pain and ROM after hand flexor tendon repair.

Inclusion Criteria:

• Ages of patients will be ranged from 20 to 35 years.
• All patients underwent flexor tendon primary direct repair
• All patients will be referred by a surgeon before starting the study procedure.

Exclusion Criteria:

• Patient with digital nerve repairs.
• Patients with associated vascular injuries requiring arterial repair.
• Patients with associated crush injuries and soft tissue loss.
• Patients with associated bone fractures.
• Patients with associated extensor tendon injuries .
• Patients with preexisting problems limiting joint motion.
• Patients with diminished cognitive capacity.
• Patients with history of previously failed repair.
• Patients with allergic reactions to certain substances in the conductive cream
• Patients with sensation impairment .